date:Dec 07, 2012
he upper incipient lethal level for Atlantic salmon, says the FDA report. As a result, itis extremely unlikely that AquAdvantage Salmon would ever be able to survive and migrate to the PacificOcean.
In the FDA briefing report, AquAdvantage salmon were also found to have high incidences of jaw erosionand focal inflammation (infection), though the defects are said to be of low magnitude and not likely to bedebilitating to fish in a production setting. What about the people who eat them? The repor